Sp1/Sp3 and PU.1 differentially regulate beta(5) integrin gene expression in macrophages and osteoblasts

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Osteoclast precursors and osteoblasts express integrin alpha(v)beta(5), crucial for bone remodeling.
• The beta(5) subunit, not alpha(v), controls the cell surface appearance of integrin alpha(v)beta(5).

Purpose of the Study:

• To investigate the regulatory mechanisms of the beta(5) promoter in macrophage (osteoclast precursor)-like and osteoblast-like cells.
• To identify transcription factors and DNA regions involved in controlling beta(5) gene expression.

Main Methods:

• Analysis of a 173-base pair proximal region of the beta(5) promoter.
• DNase I footprinting assays with macrophage and osteoblast nuclear extracts.
• Site-directed mutagenesis and transfection studies in MC3T3-E1 and J774 cell lines.

Main Results:

• Four protected regions (FP1-FP4) were identified in the beta(5) promoter by macrophage nuclear extracts; osteoblasts protected FP1-FP3.
• Sp1 and Sp3 bind to FP1, FP2, and FP3 in both cell types, acting as enhancers (FP1, FP2) or silencers (FP3).
• PU.1 binds to FP4 in macrophages, acting as a silencer, while Sp1/Sp3 sites show cell-type-specific regulation.

Conclusions:

• The beta(5) promoter contains regulatory elements with distinct roles in macrophages and osteoblasts.
• Sp1/Sp3 and PU.1 binding sites mediate cell-type-specific regulation of beta(5) gene expression, influencing integrin alpha(v)beta(5) appearance.